Molecular & cellular proteomics : MCP · 2026
Depletion-free Automated Enrichment of Serum Glycopeptides for High-Throughput Clinical Glycoproteomics.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Choi Jung Hoon, Bang Geul, Seol Jong Hyun, Choi Seong Woo, Lee Su-Min, Nguyen Bao Tan, Na Seungjin, Lee Cheol-Jung, Hwang Heeyoun, Chung Jinsoo, Park Sang-Jae, Woo Sang Myoung, Jeong Hye Gwang, Kim Jin Young
Аннотация
High-throughput and reproducible enrichment of N-glycopeptides remains a major bottleneck in large-scale and clinical glycoproteomics, despite substantial advances in mass spectrometry. Here, we present a depletion-free, high-throughput N-glycopeptide enrichment workflow (3kMAX) that combines 3 kDa molecular weight cut-off filtration with positive-pressure-driven mixed anion exchange (MAX) enrichment in a 96-well format. This platform enables parallel processing of up to 96 samples with minimal operator intervention, improving analytical throughput, robustness and inter-batch reproducibility. Systematic evaluation using human serum demonstrated that the combined workflow achieved superior glycopeptide selectivity and identification depth compared with conventional manual MAX enrichment or molecular weight cut-off filtration alone, without introducing detectable glycan-type bias. Sensitivity analysis across a fourfold range of serum input volumes (5-20 μl) showed stable identification performance and quantitative reproducibility, with 10 μl identified as an optimal standardized input. Day-to-day reproducibility assessments further confirmed consistent quantitative performance across different acquisition densities. Application of the workflow to hepatocellular carcinoma serum samples enabled reproducible, large-scale quantitative glycoproteomic profiling and revealed extensive disease-associated glycosylation remodeling, including site-specific regulation within individual proteins. Collectively, the 3kMAX platform provides a scalable solution for site-specific serum N-glycoproteomics and facilitates its translation into clinical and biomarker-oriented applications.